We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETQ
4601
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$0 ﹤0.01%
+12
New +$380
ORGS
4602
DELISTED
Orgenesis Inc. Common Stock
ORGS
$0 ﹤0.01%
+10
New +$446
ORAN
4603
DELISTED
Orange
ORAN
-670
Closed -$11K
GHSI
4604
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
-8
Closed -$3K
TELL
4605
DELISTED
Tellurian Inc.
TELL
$0 ﹤0.01%
58
-21
-27% -$151
EVA
4606
DELISTED
Enviva Inc.
EVA
-3,299
Closed -$104K
FAM
4607
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
-75
Closed -$1K
KA
4608
DELISTED
Kineta, Inc. Common Stock
KA
-49
Closed -$7K
ALIM
4609
DELISTED
Alimera Sciences
ALIM
-3,657
Closed -$49K
LSXMA
4610
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$0 ﹤0.01%
+14
New +$409
CSSE
4611
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
-20
Closed
ASLN
4612
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
-7
Closed -$1K
SCX
4613
DELISTED
The L.S. Starrett Company
SCX
-102
Closed -$1K
ALPN
4614
DELISTED
Alpine Immune Sciences Inc
ALPN
$0 ﹤0.01%
+89
New +$382
CEM
4615
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
-849
Closed -$51K
NTG
4616
DELISTED
Tortoise Midstream Energy Fund, Inc. Common Stock
NTG
-19
Closed -$3K
STAF
4617
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
0
TTOO
4618
DELISTED
T2 Biosystems, Inc
TTOO
-4
Closed -$38K
VIA
4619
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
-334
Closed -$19K
AEL
4620
DELISTED
American Equity Investment Life Holding Company
AEL
-101
Closed -$3K
CSML
4621
DELISTED
IndexIQ ETF Trust IQ U.S. Small Cap ETF
CSML
-100
Closed -$2K
NGM
4622
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-1,072
Closed -$16K
CASA
4623
DELISTED
Casa Systems, Inc. Common Stock
CASA
-2,957
Closed -$19K
BKCC
4624
DELISTED
BlackRock Capital Investment Corporation
BKCC
-2,600
Closed -$16K
THWWW
4625
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$0 ﹤0.01%
238

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.